Navigation Links
Imprimis Pharmaceuticals Announces Plans to Pursue Compounding Pharmacy Strategy in Accordance with the Recently Passed Drug Quality and Security Act
Date:12/9/2013

SAN DIEGO, Dec. 9, 2013 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a pharmaceutical company focused on commercial development of novel drug formulations and drug delivery technologies announced their intention today to pursue a compounding pharmacy strategy in 2014 and beyond.

The recently passed Drug Quality and Security Act allows large drug-compounding facilities, which mix ingredients to make a custom blend of medicine, to register as "outsourcing facilities." Imprimis continues to track recent guidance from the FDA on the newly passed law and expects to participate in the discussion related to final rules for the implementation of the law and hopes to eventually establish and voluntarily register its outsourcing facilities and be subject to these requirements and regular FDA inspection.  

"We believe that bipartisan passage of this law sends a clear signal that our leaders in Washington recognize the broad benefits of compounding pharmacies and the important role they play in the evolving healthcare delivery landscape and we applaud their creation of a regulatory framework to oversee the compounding industry, which we believe is favorable to our business strategy," said Mark L. Baum, Chief Executive Officer of Imprimis.

"Establishing centers of pharmacy excellence that use the highest standards to make and then efficiently distribute our growing portfolio of proprietary compounded drug formulations will advance Imprimis' business strategy of taking small ideas from the clinical interaction between pharmacists, physicians and their patients and turning them into big ideas for physicians across America to prescribe as a compounded drug for their patients.  We believe that this idea in practice will reduce healthcare costs and provide American
'/>"/>

SOURCE Imprimis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Imprimis Pharmaceutical Names Seasoned Ophthalmology Executive John Saharek as Vice-President of Commercialization for its Ophthalmology Division
2. Imprimis Pharmaceuticals, Inc. Announces Its Attendance at the American Academy of Ophthalmology in New Orleans, Nov. 16-19
3. Imprimis Pharmaceuticals Inc. Announces Shift in Strategic Direction
4. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property for Ophthalmic Compound Development Opportunity
5. Imprimis Pharmaceuticals, Inc. to Present at the Southern California Investor Conference on Thursday, August 8, 2013 at the Island Hotel in Newport Beach, CA. The presentation is scheduled to begin at 11 a.m. ET / 8 a.m. PT
6. Imprimis Pharmaceuticals, Inc. Receives Institutional Review Board (IRB) Approval for its Phase III Clinical Trial Protocol; Phase III Clinical Trial to Begin in 3Q 2013
7. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company
8. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
9. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
10. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
11. Imprimis Announces Key Leadership Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... , April 16, 2015 Mindray ... developer, manufacturer, and marketer of medical devices worldwide, ... Securities and Exchange Commission an Annual Report on Form ... year ended December 31, 2014. An electronic version of ... on Mindray,s investor relations website at  http://ir.mindray.com  or  ...
(Date:4/16/2015)... April 16, 2015  Hologic, Inc. (NASDAQ: ... screening study i published on-line this week ... of the American Cancer Society. The ... of Pittsburgh Medical Center, supports current consensus guidelines ii ... women 30-65 years of age be co-tested with ...
(Date:4/16/2015)... , April 16, 2015  Amgen (NASDAQ: ... first quarter financial results on Tuesday, April 21, 2015, ... announcement will be followed by a conference call with ... the call from Amgen will be Robert A. ... members of Amgen,s senior management team. Live ...
Breaking Medicine Technology:Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4Amgen Announces Webcast Of 2015 First Quarter Financial Results 2
... Revenue of $374 million grew 5 percent versus prior year ... the prior year, an increase of 77 percent ... Fiscal year 2011 financial guidance increased:  Constant currency revenue is ... be $2.18 to $2.26 per diluted share Hill-Rom ...
... Covance Inc. (NYSE: CVD ) today ... 31, 2010 of $0.45 per diluted share.  Included in ... costs from the previously-announced fourth quarter restructuring actions, partially ... from favorable income tax resolutions in the quarter. Excluding ...
Cached Medicine Technology:Hill-Rom Reports 77 Percent Growth in First Quarter Earnings Per Share 2Hill-Rom Reports 77 Percent Growth in First Quarter Earnings Per Share 3Hill-Rom Reports 77 Percent Growth in First Quarter Earnings Per Share 4Hill-Rom Reports 77 Percent Growth in First Quarter Earnings Per Share 5Hill-Rom Reports 77 Percent Growth in First Quarter Earnings Per Share 6Hill-Rom Reports 77 Percent Growth in First Quarter Earnings Per Share 7Hill-Rom Reports 77 Percent Growth in First Quarter Earnings Per Share 8Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56 2Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56 3Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56 4Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56 5Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56 6Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56 7Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56 8Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56 9Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56 10Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56 11Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56 12Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56 13
(Date:4/18/2015)... YORK (PRWEB) April 18, 2015 Review ... are hosting a ‘Strategies for Success’ program for cataract ... Surgeons meeting in San Diego, where eye surgeon Jeffrey ... for this invitation-only event. Dr. Martin is the Managing ... Review of Ophthalmology chose Dr. Martin to lead this ...
(Date:4/18/2015)... 2015 Lowcostcarinsuranceprice.com has released a new ... on auto insurance prices . , Drivers ... vehicle theft may have to pay more for auto ... insurance policies can also offer protection against vehicle theft. ... compared online on a single website: http://lowcostcarinsuranceprice.com/ ...
(Date:4/18/2015)... 2015 Patients who undergo radiation for ... later in life, but the disease is likely to ... unrelated to radiation. Surviving Mesothelioma has just posted the ... Click here to read it now. , Scientists ... of 45 patients who had both a hematologic cancer ...
(Date:4/18/2015)... In the past few weeks, TheBeautyPlace.com ... , "We had to run maintenance on our shipping ... Jennifer Ramirez, the PR Director. "It disrupted our regular ... we are back on track after having completed the ... changing phone systems which has not allowed some calls ...
(Date:4/18/2015)... 18, 2015 On April 14th, 2015, Symantec ... , which they say, “exposes a tactical shift by cyberattackers.” ... variants were introduced in 2014 - almost a million a ... threats to be identified and patched by prominent manufacturers – ... that doing business in a digital world can be fraught ...
Breaking Medicine News(10 mins):Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:TheBeautyPlace.com Temporary Number Available 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5
... children fail to reach their full potential because they ... care, according to new research funded by the Economic ... disabled children often experience discrimination, exclusion and even violence," ... implemented the study at the Manchester Metropolitan University. "The ...
... HealthDay Reporter , THURSDAY, Dec. 1 (HealthDay News) ... issued new guidelines aimed at helping speed up the ... a reality, such technologies could make a huge difference ... injections to control their blood sugar and survive. ...
... candidates want to be involved in decisions regarding quality ... accept organs with a higher risk of failure, according ... than 42 percent of patients would choose to remain ... quality" liver according to the study,s lead author Michael ...
... THURSDAY, Dec. 1 (HealthDay News) -- ,The timing of an ... death, a new study finds. For example, there,s no ... afternoon versus the morning or on Monday instead of Friday, ... that fatigue may lead to a higher rate of safety ...
... likely to stick to prescribed treatment when a partner ... a team of sleep researchers. Obstructive sleep apnea occurs ... the most common type of sleep-disordered breathing, and chances ... The first line of treatment for sleep apnea is ...
... , THURSDAY, Dec. 1 (HealthDay News) -- Optimism ... marks for males, a new study suggests. Researchers at ... and grades of 174 business undergraduates (28 percent male, 72 ... that female students who were more optimistic had higher grades ...
Cached Medicine News:Health News:Disabled children do matter 2Health News:Disabled children do matter 3Health News:FDA Moves to Speed Development of Artificial Pancreas Systems 2Health News:FDA Moves to Speed Development of Artificial Pancreas Systems 3Health News:Transplant candidates seek best quality livers, even if it means waiting longer 2Health News:Time of Surgery Doesn't Influence Results, Study Says 2Health News:Innovative approaches help sleep apnea sufferers benefit from CPAP 2
The Horizontal-Vertical (H/V) lumbar valve system is the only differential pressure valve for lumbo-peritoneal shunting, which addresses orthostatic overdrainage....
26 cm - 10 1/4, 140 mm - 5 1/2, bayonet-shaped, flexible, 90 angle, 4 mm...
Toothed pituitary rongeur. Straight....
Micro pituitary style scissors, alligator action, semi-malleable shaft. Curved right....
Medicine Products: